PDE4A and respiratory system disorder: Phosphodiesterase-4 (PDE4), which specifically catalyzes the hydrolysis of cyclic adenosine monophosphate (cAMP), is a therapeutic target of high interest for central nervous system (CNS), inflammatory, and respiratory diseases [24].